Evaluation of a provocative dyspnea severity score in acute heart failure

American Heart Journal

Volumn 172, Issue , 2016, Pages 34-41

  AbouEzzeddine, Omar F ^a   Lala, Anuradha ^b,c   Khazanie, Prateeti P ^d   Shah, Ravi ^e   Ho, Jennifer E ^f   Chen, Horng H ^a   Pang, Peter S ^g   McNulty, Steven E ^h   Anstrom, Kevin J ^h   Hernandez, Adrian F ^h   Redfield, Margaret M ^a  

^a MAYO CLINIC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MOUNT SINAI HOSPITAL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g INDIANA UNIVERSITY   (United States)

^h DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; DYSPNEA VISUAL ANALOG SCALE; EXERCISE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROVOCATION TEST; PROVOCATIVE DYSPNEA SEVERITY SCORE; RESPIRATORY TRACT DISEASE ASSESSMENT; SCORING SYSTEM; SENSITIVITY ANALYSIS; VISUAL ANALOG SCALE; ACUTE DISEASE; BLOOD; COMPLICATION; EXERCISE TEST; FEASIBILITY STUDY; FOLLOW UP; HEART FAILURE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ACUTE DISEASE; AGED; BIOMARKERS; DYSPNEA; EXERCISE TEST; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84960158154     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.10.009     Document Type: Article

References (20)

1. C.W. Yancy, M. Jessup, B. Bozkurt, and et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
2. J. Lindenfeld, N.M. Albert, J.P. Boehmer, and et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline J Card Fail 16 2010 e1 e194
3. R.L. West, A.F. Hernandez, C.M. O'Connor, and et al. A review of dyspnea in acute heart failure syndromes Am Heart J 160 2010 209 214
4. J.R. Teerlink Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure Am Heart J 145 2003 S26 S33
5. P.S. Pang, M. Komajda, and M. Gheorghiade The current and future management of acute heart failure syndromes Eur Heart J 31 2010 784 793
6. A. Mebazaa, P.S. Pang, M. Tavares, and et al. The impact of early standard therapy on dyspnea in patients with acute heart failure: the URGENT-dyspnea study Eur Heart J 31 2010 832 841
7. P.S. Pang, J.G. Cleland, J.R. Teerlink, and et al. A proposal to standardize dyspnea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach Eur Heart J 29 2008 816 824
8. H.H. Chen, K.J. Anstrom, M.M. Givertz, and et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial JAMA 310 2013 2533 2543
9. H.H. Chen, O.F. AbouEzzeddine, K.J. Anstrom, and et al. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial Circ Heart Fail 6 2013 1087 1094
10. J.J. McMurray, J.R. Teerlink, G. Cotter, and et al. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JAMA 298 2007 2009 2019
11. J.R. Teerlink, G. Cotter, B.A. Davison, and et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial Lancet 381 2013 29 39
12. N.V. Kommuri, M.L. Johnson, and T.M. Koelling Six-minute walk distance predicts 30-day readmission in hospitalized heart failure patients Arch Med Res 4 2010 363 368
13. M.T. Alahdab, I.N. Mansour, S. Napan, and et al. Six minute walk test predicts long-term all-cause mortality and heart failure rehospitalization in African-American patients hospitalized with acute decompensated heart failure J Card Fail 15 2009 130 135
14. J. Howie-Esquivel, and K. Dracup Effect of gender, ethnicity, pulmonary disease, and symptom stability on rehospitalization in patients with heart failure Am J Cardiol 100 2007 1139 1144
15. M. Feola, S. Garnero, P. Vallauri, and et al. Relationship between cognitive function, depression/anxiety and functional parameters in patients admitted for congestive heart failure Open Cardiovasc Med J 7 2013 54 60
16. G.M. Felker, K.L. Lee, D.A. Bull, and et al. NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
17. M. Kato, L.W. Stevenson, M. Palardy, and et al. The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy J Card Fail 18 2012 524 533
18. R.D. Kociol, S.E. McNulty, A.F. Hernandez, and et al. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure Circ Heart Fail 6 2013 240 245
19. R.J. Mentz, A.F. Hernandez, A. Stebbins, and et al. Predictors of early dyspnea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF Eur J Heart Fail 15 2013 456 464
20. M. Metra, C.M. O'Connor, B.A. Davison, and et al. Early dyspnea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study Eur Heart J 32 2011 1519 1534